{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:57:07Z","timestamp":1791291427317,"version":"4.3.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2003,4,1]],"date-time":"2003-04-01T00:00:00Z","timestamp":1049155200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":4628,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2003,4]]},"DOI":"10.1046\/j.1523-1747.2003.12097.x","type":"journal-article","created":{"date-parts":[[2004,12,27]],"date-time":"2004-12-27T08:36:36Z","timestamp":1104136596000},"page":"542-547","source":"Crossref","is-referenced-by-count":103,"title":["Function Blocking Autoantibodies Against Matrix Metalloproteinase-1 in Patients with Systemic Sclerosis"],"prefix":"10.1016","volume":"120","author":[{"given":"Shinichi","family":"Sato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikuko","family":"Hayakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minoru","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Takehara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manabu","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1046\/j.1523-1747.2003.12097.x_bb0010","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis (first of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1523-1747.2003.12097.x_bb0015","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM197502202920807","article-title":"Polymyositis and dermatomyositis (second of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N Eng J Med"},{"key":"10.1046\/j.1523-1747.2003.12097.x_bb0020","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/art.1780350606","article-title":"the Committee on Prognosis Studies in SLE: Derivation of the SLEDAI. a disease activity index for lupus patients","volume":"35","author":"Bombardier","year":"1992","journal-title":"Arthritis Rheum"},{"key":"10.1046\/j.1523-1747.2003.12097.x_bb0025","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0009-8981(94)90255-0","article-title":"Excess matrix accumulation in scleroderma is caused partly by differential regulation of stromelysin and TIMP-1 synthesis","volume":"231","author":"Bou Gharios","year":"1994","journal-title":"Clin Chem Acta"},{"key":"10.1046\/j.1523-1747.2003.12097.x_bb0030","first-page":"1892","article-title":"Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies","volume":"20","author":"Clements","year":"1993","journal-title":"J Rheumatol"},{"key":"10.1046\/j.1523-1747.2003.12097.x_bb0035","first-page":"111","article-title":"Tissue inhibitors of metalloproteinases: structure, regulation and biological functions","volume":"74","author":"Gomez","year":"1997","journal-title":"Eur J Cell Biol"},{"key":"10.1046\/j.1523-1747.2003.12097.x_bb0040","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0889-857X(05)70294-5","article-title":"Pathogenesis of scleroderma: Collagen","volume":"22","author":"Jimenez","year":"1996","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1046\/j.1523-1747.2003.12097.x_bb0045","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/sj.gene.6363768","article-title":"Lack of association of a functionally relevant single nucleotide polymorphism of matrix metalloproteinase-1 promoter with systemic sclerosis (scleroderma)","volume":"2","author":"Johnson","year":"2001","journal-title":"Genes Immun"},{"key":"10.1046\/j.1523-1747.2003.12097.x_bb0050","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1600-0625.1997.tb00164.x","article-title":"Matrix metalloproteinases in skin","volume":"6","author":"K\u00e4h\u00e4ri","year":"1997","journal-title":"Exp Dermatol"},{"key":"10.1046\/j.1523-1747.2003.12097.x_bb0055","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/0190-9622(95)90289-9","article-title":"Serum tissue inhibitor of metalloproteinases in patients with systemic sclerosis","volume":"33","author":"Kikuchi","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"10.1046\/j.1523-1747.2003.12097.x_bb0060","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/1523-1747.ep12286457","article-title":"Tissue inhibitor of metalloproteinase 1 (TIMP-1) may be an autocrine growth factor in scleroderma fibroblasts","volume":"108","author":"Kikuchi","year":"1997","journal-title":"J Invest Dermatol"},{"key":"10.1046\/j.1523-1747.2003.12097.x_bb0065","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.1074\/jbc.270.7.3423","article-title":"Myofibroblasts from scleroderma skin synthesize elevated levels of collagen and tissue inhibitor of metalloproteinase (TIMP-1) with two forms of TIMP-1","volume":"270","author":"Kirk","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1046\/j.1523-1747.2003.12097.x_bb0070","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S1074-7613(00)80045-X","article-title":"From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins","volume":"10","author":"Korganow","year":"1999","journal-title":"Immunity"},{"key":"10.1046\/j.1523-1747.2003.12097.x_bb0075","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s004030050241","article-title":"Gene expression of types I and III collagen, decorin, matrix metalloproteinases and tissue inhibitors of metalloproteinases in skin fibroblasts from patients with systemic sclerosis","volume":"289","author":"Kuroda","year":"1997","journal-title":"Arch Dermatol Res"},{"key":"10.1046\/j.1523-1747.2003.12097.x_bb0080","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1172\/JCI107827","article-title":"Increased collagen synthesis by scleroderma skin fibroblasts in vitro: A possible defect in the regulation or activation of the scleroderma fibroblast","volume":"54","author":"LeRoy","year":"1974","journal-title":"J Clin Invest"},{"key":"10.1046\/j.1523-1747.2003.12097.x_bb0085","first-page":"202","article-title":"Scleroderma (systemic sclerosis): Classification, subsets, and pathogenesis","volume":"15","author":"LeRoy","year":"1988","journal-title":"J Rheumatol"},{"key":"10.1046\/j.1523-1747.2003.12097.x_bb0090","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1083\/jcb.130.1.227","article-title":"A targeted mutation at the known collagenase cleavage site in mouse type I collagen impairs tissue remodeling","volume":"130","author":"Liu","year":"1995","journal-title":"J Cell Biol"},{"key":"10.1046\/j.1523-1747.2003.12097.x_bb0095","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1365-2133.1979.tb01635.x","article-title":"Characterization of dermal collagen in systemic sclerosis","volume":"100","author":"Lovell","year":"1979","journal-title":"Br J Dermatol"},{"key":"10.1046\/j.1523-1747.2003.12097.x_bb0100","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/ni772","article-title":"How antibodies to a ubiquitous cytoplasmic enzyme may provoke joint-specific autoimmune disease","volume":"3","author":"Matsumoto","year":"2002","journal-title":"Nat Immunol"},{"key":"10.1046\/j.1523-1747.2003.12097.x_bb0105","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1046\/j.1523-1747.1998.00138.x","article-title":"Activation of tissue inhibitor of metalloproteinases-3 (TIMP-3) mRNA expression in scleroderma skin fibroblasts","volume":"110","author":"Mattila","year":"1998","journal-title":"J Invest Dermatol"},{"key":"10.1046\/j.1523-1747.2003.12097.x_bb0110","doi-asserted-by":"crossref","first-page":"21491","DOI":"10.1074\/jbc.274.31.21491","article-title":"Matrix metalloproteinases","volume":"274","author":"Nagase","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1046\/j.1523-1747.2003.12097.x_bb0115","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1093\/rheumatology\/40.4.406","article-title":"Renal vascular damage in Japanese patients with systemic sclerosis","volume":"40","author":"Nishijima","year":"2001","journal-title":"Rheumatology"},{"key":"10.1046\/j.1523-1747.2003.12097.x_bb0120","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0889-857X(05)70297-0","article-title":"Anti-nuclear antibody in systemic sclerosis (scleroderma)","volume":"22","author":"Okano","year":"1996","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1046\/j.1523-1747.2003.12097.x_bb0125","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1172\/JCI0215078","article-title":"CD19-dependent B lymphocyte signaling thresholds influence skin fibrosis and autoimmunity in the tight-skin mouse","volume":"109","author":"Saito","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1046\/j.1523-1747.2003.12097.x_bb0130","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/00002281-199911000-00010","article-title":"Abnormalities of adhesion molecules and chemokines in scleroderma","volume":"11","author":"Sato","year":"1999","journal-title":"Curr Opin Rheumatol"},{"key":"10.1046\/j.1523-1747.2003.12097.x_bb0135","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/art.1780370313","article-title":"Antihistone antibodies in systemic sclerosis: Association with pulmonary fibrosis","volume":"37","author":"Sato","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1046\/j.1523-1747.2003.12097.x_bb0140","doi-asserted-by":"crossref","first-page":"6635","DOI":"10.4049\/jimmunol.165.11.6635","article-title":"Quantitative genetic variation in CD19 expression correlates with autoimmunity","volume":"165","author":"Sato","year":"2000","journal-title":"J Immunol"},{"key":"10.1046\/j.1523-1747.2003.12097.x_bb0145","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1093\/rheumatology\/40.10.1135","article-title":"Clinical significance of anti-topoisomerase I antibody levels by ELISA in systemic sclerosis","volume":"40","author":"Sato","year":"2001","journal-title":"Rheumatology"},{"key":"10.1046\/j.1523-1747.2003.12097.x_bb0150","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0889-857X(05)70303-3","article-title":"Clinical problems: The lungs","volume":"22","author":"Silver","year":"1996","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1046\/j.1523-1747.2003.12097.x_bb0155","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/art.1780310207","article-title":"Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis","volume":"31","author":"Steen","year":"1988","journal-title":"Arthritis Rheum"},{"key":"10.1046\/j.1523-1747.2003.12097.x_bb0160","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1172\/JCI6870","article-title":"Matrix metalloproteinases in angiogenesis: A moving target for therapeutic intervention","volume":"103","author":"Stetler-Stevenson","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1046\/j.1523-1747.2003.12097.x_bb0165","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/art.1780230510","article-title":"Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee: Preliminary criteria for the classification of systemic sclerosis (scleroderma)","volume":"23","year":"1980","journal-title":"Arthritis Rheum"},{"key":"10.1046\/j.1523-1747.2003.12097.x_bb0170","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/1523-1747.ep12394936","article-title":"Decreased collagenase expression in cultured systemic sclerosis fibroblasts","volume":"103","author":"Takeda","year":"1994","journal-title":"J Invest Dermatol"},{"key":"10.1046\/j.1523-1747.2003.12097.x_bb0175","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/art.1780251101","article-title":"The 1982 revised criteria for the classification of systemic lupus erythematosus","volume":"25","author":"Tan","year":"1982","journal-title":"Arthritis Rheum"},{"key":"10.1046\/j.1523-1747.2003.12097.x_bb0180","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1148\/radiology.169.2.3051113","article-title":"Unusual causes of increased vascular impedance in renal transplants: Duplex doppler evaluation","volume":"169","author":"Warshauer","year":"1988","journal-title":"Radiology"},{"key":"10.1046\/j.1523-1747.2003.12097.x_bb0185","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0190-9622(00)90011-2","article-title":"Serum levels of tissue inhibitor of metalloproteinases 2 in patients with systemic sclerosis","volume":"42","author":"Yazawa","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1046\/j.1523-1747.2003.12097.x_bb0190","first-page":"846","article-title":"Serum TIMP-1, TIMP-2, and MMP-1 in patients with systemic sclerosis, primary Raynaud's phenomenon, and in normal controls","volume":"60","author":"Young-Min","year":"2001","journal-title":"Ann Rheum Dis"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15302086?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15302086?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,30]],"date-time":"2019-01-30T10:56:48Z","timestamp":1548845808000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X15302086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,4]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2003,4]]}},"alternative-id":["S0022202X15302086"],"URL":"https:\/\/doi.org\/10.1046\/j.1523-1747.2003.12097.x","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2003,4]]}}}